Search Results - "Tvedten, T"
-
1
-
2
-
3
EPA-0513 – Methylphenidate hydrochloride modified release (mph-la) maintained efficacy over long-term in the treatment of adult attention deficit hyperactivity disorder (adhd)
Published in European psychiatry (2014)“…Introduction Previously, we reported the clinical efficacy of MPH-LA in adult ADHD evaluated in a 40-week, randomised, double-blind, placebo-controlled,…”
Get full text
Journal Article -
4
EPA-0626 – Long-term safety of methylphenidate hydrochloride modified release (MPH-LA) in the treatment of attention deficit hyperactivity disorder (ADHD) in adults
Published in European psychiatry (2014)“…Introduction A previous 40-week, randomised, double-blind placebo-controlled core study [comprising of dose confirmation (9-week), real-life dose optimisation…”
Get full text
Journal Article -
5
1082 – 40-week, randomized, double-blind, placebo-controlled, multicenter, efficacy and safety study of methylphenidate hydrochloride modified release (MPH-LA) in adults with attention deficit hyperactivity disorder (ADHD)
Published in European psychiatry (2013)“…Introduction Recent epidemiology studies have reported the prevalence of adult ADHD to be approximately 4%, however approved treatments are limited. Objectives…”
Get full text
Journal Article -
6
Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial
Published in Advances in therapy (01-01-2014)“…Introduction Treatment options for adults with attention deficit hyperactivity disorder (ADHD) are limited. The study was conducted to confirm the clinically…”
Get full text
Journal Article -
7
-
8
-
9
-
10
Methylphenidate hydrochloride modified release led to a beneficial impact on family-, work- and social life in adult ADHD patients
Published in EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)Get full text
Conference Proceeding -
11
Methylphenidate hydrochloride modified release improved inattention and hyperactivity/impulsivity scores in adult ADHD patients
Published in EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)Get full text
Conference Proceeding